Future perspectives for acute promyelocytic leukemia therapy

被引:3
作者
Cassinat, B [1 ]
Chomienne, C [1 ]
机构
[1] Hop St Louis, INSERM E0003, Lab Biol Cellulaire Hematopoiet, F-75010 Paris, France
关键词
D O I
10.1053/shem.2001.20870
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:86 / 91
页数:6
相关论文
共 31 条
[1]
ALL-TRANS-RETINOIC ACID PHARMACOKINETICS AND BIOAVAILABILITY IN ACUTE PROMYELOCYTIC LEUKEMIA - INTRACELLULAR CONCENTRATIONS AND BIOLOGIC RESPONSE RELATIONSHIP [J].
AGADIR, A ;
CORNIC, M ;
LEFEBVRE, P ;
GOURMEL, B ;
JEROME, M ;
DEGOS, L ;
FENAUX, P ;
CHOMIENNE, C .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2517-2523
[2]
BREITMAN TR, 1981, BLOOD, V57, P1000
[3]
Cassinat B, 1998, BLOOD, V92, p596A
[4]
Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia [J].
Charrad, RS ;
Li, Y ;
Delpech, B ;
Balitrand, N ;
Clay, D ;
Jasmin, C ;
Chomienne, C ;
Smadja-Joffe, F .
NATURE MEDICINE, 1999, 5 (06) :669-676
[5]
Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells [J].
Chelbi-Alix, MK ;
Pelicano, L .
LEUKEMIA, 1999, 13 (08) :1167-1174
[6]
CHOMIENNE C, 1990, BLOOD, V76, P1710
[7]
Retinoid differentiation therapy in promyelocytic leukemia [J].
Chomienne, C ;
Fenaux, P ;
Degos, L .
FASEB JOURNAL, 1996, 10 (09) :1025-1030
[8]
Chomienne C, 1991, Baillieres Clin Haematol, V4, P47, DOI 10.1016/S0950-3536(05)80284-7
[9]
DASILVA N, IN PRESS HEMATOL J
[10]
DELVA L, 1993, BLOOD, V82, P2175